Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology

Advanced search

COMPARISON OF RECOMMENDED SCREENING PROGRAMS IN THE UNITED STATES, CANADA, THE NETHERLANDS AND GERMANY

https://doi.org/10.17749/2070-4909.2016.9.4.046-053

Full Text:

Abstract

This publication presents a comparison of recommendations of screening programs and prevention activities in the United States, Canada, the Netherlands and Germany for adult non-pregnant population excluding infectious diseases. Sources of funding for such programs and information about their implementation are descripted. According to the search results of the relevant information in open sources, a list of recommended screening programs, as well as the amount of available information describing these programs in foreign countries varies.

About the Authors

V. S. Dombrovskiy
The Russian Presidential Academy of National Economy and Public Administration
Russian Federation

researcher at the Laboratory for Health Technology Assessment at the Institute of Applied Economic Research of the Russian Presidential Academy of National Economy and Public Administration. Address: Vernadskogo prospect, 82-1, Moscow, Russia, 119571. Tel.: +7(499)9569528



G. R. Khachatryan
The Russian Presidential Academy of National Economy and Public Administration Research Institute of Finance, Ministry of Finance of the Russian Federation
Russian Federation

researcher at the Laboratory for Health Technology Assessment at the Institute of Applied Economic Research of the Russian Presidential Academy of National Economy and Public Administration, junior researcher of the Center for Healthcare Funding of the Financial Scientific Research Institute at the Ministry of Finance of the Russian Federation. Address: Vernadskogo prospect, 82-1, Moscow, Russia, 119571. Tel.: +7(499)9569528



References

1. Avksent’eva M. V., Omel’yanovskii V. V. Meditsinskie tekhnologii. Otsenka i vybor. 2010; 1: 52-58.

2. Pyadushkina E. A., Avksent’eva M. V., Omel’yanovskii V. V. Meditsinskie tekhnologii. Otsenka i vybor. 2016; 3: 20-33.

3. Chto takoe Medicare? URL: https://www.medicare.gov/pubs/pdf/other-languages-not-sp/11306-R.pdf. Accessed: 25.11.2016

4. Andermann A., Blancquaert I., Beauchamp S., Dйry V. Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. Bull World Health Organ. 2008; 86 (4): 317-319. URL: http://www.who.int/bulletin/volumes/86/4/07- 050112/en/. Accessed: 25.11.2016

5. Atrial Fibrillation. URL: http://canadiantaskforce.ca/appraised-guidelines/2014-atrial-fibrillation/. Accessed: 25.11.2016

6. Colorectal Cancer (2016). URL: http://canadiantaskforce.ca/ctfphc-guidelines/2015-colorectal-cancer/. Accessed: 25.11.2016

7. Early detection examinations covered by statutory health insurance. URL: http://www.english.g-ba.de/special-topics/prevention/detection/. Accessed: 25.11.2016

8. Holland W. W., Stewart S. Screening in Disease Prevention: What Works? Oxford: Radcliffe Publishing Ltd in association with The Nuffield Trust and the European Observatory on Health Systems and Policies. 2005. URL: http://www.euro.who.int/__data/assets/pdf_file/0007/108961/E88698.pdf. Accessed: 25.11.2016

9. Lung Cancer (2016). URL: http://canadiantaskforce.ca/ctfphc-guidelines/2015-lung- cancer/. Accessed: 25.11.2016

10. Melanoma. URL: http://canadiantaskforce.ca/appraised-guidelines/2013-melanoma/. Accessed: 25.11.2016

11. Obesity in Adults (2015). URL: http://canadiantaskforce.ca/ctfphc-guidelines/2015-obesity-adults/. Accessed: 25.11.2016

12. Osteoporosis. URL: http://canadiantaskforce.ca/appraised-guidelines/2013-osteoporosis/. Accessed: 25.11.2016

13. Population Screening Act: Renewal of nationwide cervical cancer screening programme. URL: https://www.gezondheidsraad.nl/en/task-and-procedure/areas-of- activity/prevention/population-screening-act-renewal-of-nationwide. Accessed: 25.11.2016

14. Population Screening Act: study of faecal tests within the population based screening programme for colorectal cancer. URL: https://www.gezondheidsraad.nl/en/task-and-procedure/areas-of-activity/prevention/population-screening-act-study-of-faecal-tests. Accessed: 25.11.2016

15. Population Screening Act: pressureguided compression for breast cancer screening. URL: https://www.gezondheidsraad.nl/en/task-and-procedure/areas-of-activity/prevention/population-screening-act-pressureguided-compression. Accessed: 25.11.2016

16. Preventive & screening services. URL: https://www.medicare. gov/coverage/preventive-and-screening-services.html. Accessed: 25.11.2016

17. Screening for Breast Cancer (2011). URL: http://canadiantaskforce.ca/ctfphc- guidelines/2011-breast-cancer/. Accessed: 25.11.2016

18. Screening for Cervical Cancer (2013). URL: http://canadiantaskforce.ca/ctfphc- guidelines/2013-cervical-cancer/. Accessed: 25.11.2016

19. Screening for Depression (2013). URL: http://canadiantaskforce.ca/ctfphc- guidelines/2013-depression/. Accessed: 25.11.2016

20. Screening for Hypertension (2012). URL: http://canadiantaskforce.ca/ctfphc-guidelines/2012-hypertension/. Accessed: 25.11.2016

21. Screening for Prostate Cancer (2014). URL: http://canadiantaskforce.ca/ctfphc-guidelines/2014-prostate-cancer/. Accessed: 25.11.2016

22. Screening for Type 2 Diabetes (2012). URL: http://canadiantaskforce.ca/ctfphc- guidelines/2012-type-2-diabetes/. Accessed: 25.11.2016

23. Seedat F., Cooper J., Stranges S., Kandala N. B., Taylor-Phillips S. International comparisons of screening policy-making: A systematic review. National Screening Committee. 2014. URL: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/444227/FI NAL_REPORT_International_Screening.pdf. Accessed: 25.11.2016

24. USPSTF A and B Recommendations. U. S. Preventive Services Task Force. April 2016. URL: http://www.uspreventiveservicestaskforce.org/Page/Name/uspstf-a-and-b- recommendations/. Accessed: 25.11.2016


For citation:


Dombrovskiy V.S., Khachatryan G.R. COMPARISON OF RECOMMENDED SCREENING PROGRAMS IN THE UNITED STATES, CANADA, THE NETHERLANDS AND GERMANY. FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology. 2016;9(4):46-53. (In Russ.) https://doi.org/10.17749/2070-4909.2016.9.4.046-053

Views: 278


ISSN 2070-4909 (Print)
ISSN 2070-4933 (Online)